FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGFbeta1/SMAD2/3 signaling pathway in ovarian cancer

Ovarian cancer is one of the most common gynecological malignancies due to the lack of early symptoms, early diagnosis and limited screening. Therefore, it is necessary to understand the molecular mechanism underlying the occurrence and progression of ovarian cancer and to identify a basic biomarker for the early diagnosis and clinical treatment of ovarian cancer.